Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The role of perfusion data.

E Rapaport1

  • 1Department of Medicine, University of California, School of Medicine, San Francisco.

European Heart Journal
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Thrombolytic agents like streptokinase significantly reduce mortality in acute myocardial infarction. Further research is needed to understand the full benefits and compare different agents for optimal patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the acute coronary syndromes.

Current cardiology reports·2001
Same author

Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease?

European heart journal·2000
Same author

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Journal of the American College of Cardiology·1999
Same author

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Circulation·1999
Same author

Mapping of HIV-1 determinants of apoptosis in infected T cells.

Virology·1999
Same author

Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

Proceedings of the National Academy of Sciences of the United States of America·1998

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) is a leading cause of mortality.
  • Thrombolytic therapy is a cornerstone treatment for AMI.
  • Early administration of thrombolytics improves outcomes, but mechanisms are not fully understood.

Purpose of the Study:

  • To evaluate the mortality benefit of thrombolytic agents in early AMI.
  • To explore the relationship between early patency rates and mortality reduction.
  • To highlight the need for comparative studies of different thrombolytic agents.

Main Methods:

  • Review of existing data on thrombolytic agents (streptokinase, t-PA, APSAC).
  • Analysis of mortality rates in patients receiving thrombolytic therapy within the early hours of AMI.
  • Discussion of the limitations of using early patency rates as the sole indicator of benefit.

Related Experiment Videos

Main Results:

  • Thrombolytic agents demonstrate a profound benefit in reducing mortality in early AMI.
  • The observed mortality reduction is not fully explained by early vessel patency rates alone.
  • Randomized trials directly comparing thrombolytic agents are crucial.

Conclusions:

  • Thrombolytic therapy is essential for reducing mortality in acute myocardial infarction.
  • Further investigation is required to elucidate the mechanisms behind mortality reduction.
  • Comparative randomized studies (e.g., GISSI-II, ISIS-III) are necessary to guide the choice of thrombolytic agent.